Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03914846 · ClinicalTrials.gov registry record · NA
Ultrasound in Diagnosing Patients With Skin Lesions
A NA study of Skin Lesion, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT03914846 is a NA study of Skin Lesion that has completed, run by Emory University. The registered enrollment target is 47 participants, below the 1,783-participant average among 3 other Skin Lesion trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03914846, a NA study of Skin Lesion, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies the use of a novel non-invasive ultrasound technique in diagnosing patents with skin lesions. Diagnostic procedures, such as ultrasound, may be a less invasive way to check skin lesions for skin cancer and other skin disorders.
Conditions Studied
Interventions
- PROCEDURE Ultrasound
Study Locations (1)
Georgia
- Emory University Hospital/Winship Cancer Institute - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2019-04-29 |
| Est. Completion | 2022-10-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03914846
The ClinicalTrials.gov registry entry for NCT03914846 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,783-participant average among 3 other Skin Lesion trials with a reported enrollment target (97% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Lesion appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound is the first listed.
NCT03914846 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT03914846 about?
NCT03914846 is a clinical study titled "Ultrasound in Diagnosing Patients With Skin Lesions". This trial studies the use of a novel non-invasive ultrasound technique in diagnosing patents with skin lesions. Diagnostic procedures, such as ultrasound, may be a less invasive way to check skin lesions for skin cancer and other skin disorders.
What is the current status of trial NCT03914846?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2019-04-29. Estimated completion is 2022-10-20.
What conditions does trial NCT03914846 study?
This clinical trial studies the following conditions: Skin Lesion.
What interventions are being tested in trial NCT03914846?
The interventions under investigation include: Ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT03914846?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03914846 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Lesion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.